Literature DB >> 27516392

Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation.

Mahmoud Abdelwahab Ali1, Mohamed Morsi Elshobari1, Tarek Salah1, Al-Refaey Kandeel2, Ahmad Mohammad Sultan1, Ahmad Nabieh Elghawalby1, Ahmed Shehta1, Usama Elsayed2, Omar Fathy1, Amr Yassen2, Mohamed Abdel Wahab1.   

Abstract

Living donor liver transplantation (LDLT) is a valuable option for expanding the donor pool, especially in localities where deceased organ harvesting is not allowed. In addition, rejection rates were found to be lower in LDLT, which is attributed to the fact that LDLT is usually performed between relatives. However, the impact of genetic relation on the outcome of LDLT has not been studied. In this study, we examined the difference in rejection rates between LDLT from genetically related (GR) donors and genetically unrelated (GUR) donors. All cases that underwent LDLT during the period from May 2004 until May 2014 were included in the study. The study group was divided into 2 groups: LDLT from GR donors and LDLT from GUR donors. A total of 308 patients were included in the study: 212 from GR donors and 96 from GUR donors. Human leukocyte antigen (HLA) typing was not included in the workup for matching donors and recipients. GUR donors were wives (36; 11.7%), sons-in-law (7; 2.3%), brothers-in-law (12; 3.9%), sisters-in-law (1; 0.3%), and unrelated (38; 12.3%). The incidence of acute rejection in the GR group was 17.4% and 26.3% in the GUR group (P value = 0.07). However, there was a significant difference in the incidence of chronic rejection (CR) between the 2 groups: 7% in GR group and 14.7% in the GUR group (P value = 0.03). In terms of overall survival, there was no significant difference between both groups. LDLT from the GUR donors is not associated with a higher incidence of acute cellular rejection. However, CR was significantly lower when grafts were procured from GR donors. HLA matching may be recommended before LDLT from GUR donors. Liver Transplantation 23:43-49 2017 AASLD.
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27516392     DOI: 10.1002/lt.24599

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  4 in total

Review 1.  Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rinkesh K Bansal; Neeraj Saraf; Dheeraj Gautam; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-11-07

2.  Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Srikanth Thummala; Neeraj Saraf; Amit Rastogi; Prashant Bhangui; Thiagrajan Srinivasan; Sanjay K Yadav; Samiran Nundy; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-02-14

3.  Do Recipients of Genetically Related Donors Have Better Outcomes After Living Donor Liver Transplantation?

Authors:  Narendra S Choudhary; Sujeet K Saha; Sanjiv Saigal; Dheeraj Gautam; Neeraj Saraf; Amit Rastogi; Prashant Bhangui; Srinivasan Thiagrajan; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2019-12-27

Review 4.  Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation.

Authors:  Zhengtao Liu; Jun Xu; Shuping Que; Lei Geng; Lin Zhou; Adil Mardinoglu; Shusen Zheng
Journal:  J Clin Transl Hepatol       Date:  2022-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.